Catalyst Wire Dossier Catalyst Wire Dossier

VXA-A1.1 oral H1 vaccine

VXA-A1.1 · Vaxart, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VXA-A1.1 oral H1 vaccine, covering 2018-05-30 to 2018-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults [Phase 1]

See pricing